HAMNO
CAS: 138736-73-9
Rif. 3D-NFA73673
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione | ||
100mg | Fuori produzione |
Informazioni sul prodotto
HAMNO is a molecule that can activate the immune system by binding to microbial antigens, such as those found in cancer cells. The HAMNO molecule is able to bind to human dna replication and inhibit HDACs, which are catalytic subunits of histone deacetylases. This inhibition causes an increase in the expression of genes involved in protein synthesis and cell proliferation, which may lead to cancer. In addition, HAMNO has the ability to synergistically work with etoposide and other anticancer drugs by inhibiting cancer cells more effectively than when used alone.